Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florence E Roufosse

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Orphanet Journal of Rare Diseases|September 13, 2007
Hypereosinophilic syndromesFlorence E Roufosse, Michel Goldman, Elie Cogan
The Journal of Allergy and Clinical Immunology|October 9, 2012
Long-term safety of mepolizumab for the treatment of hypereosinophilic syndromesFlorence E Roufosse, Jean-Emmanuel Kahn, Gerald J Gleich, et al.
The New England Journal of Medicine|March 18, 2008
Treatment of patients with the hypereosinophilic syndrome with mepolizumabMarc E Rothenberg, Amy D Klion, Florence E Roufosse, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Orphanet Journal of Rare Diseases|September 13, 2007
Hypereosinophilic syndromesFlorence E Roufosse, Michel Goldman, Elie Cogan
The Journal of Allergy and Clinical Immunology|October 9, 2012
Long-term safety of mepolizumab for the treatment of hypereosinophilic syndromesFlorence E Roufosse, Jean-Emmanuel Kahn, Gerald J Gleich, et al.
The New England Journal of Medicine|March 18, 2008
Treatment of patients with the hypereosinophilic syndrome with mepolizumabMarc E Rothenberg, Amy D Klion, Florence E Roufosse, et al.
Pageof 1